Unichem Laboratories' share price rose 4 percent intraday on December 1 after the company received ANDA approval for its Atenolol and Chlorthalidone tablets.

                       

The company has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50  mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations Ltd.

Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure.The product will be commercialized from Unichem’s Ghaziabad Plant.

At 09:46 hrs Unichem Laboratories was quoting at Rs 262.05, up Rs 6.70, or 2.62 percent on the BSE.